Compare Analog Devices, Inc. (ADI) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Analog Devices, Inc. vs Humana Inc — how do they compare? Analog Devices, Inc. trades at $382.01 (market cap $187.25B), while Humana Inc trades at $384.5 (market cap $46.69B). The key difference: Analog Devices, Inc. is far larger — about 4× Humana Inc's market cap, and Analog Devices, Inc. pays the higher dividend (1.14%). Which is the better fit depends on your goals.
| ADI | HUM | |
|---|---|---|
Market Cap | $187.25B | $46.69B |
Sector | Technology | Health |
52-Week High | $445.48 | $409.42 |
52-Week Low | $225.20 | $163.67 |
Enterprise Value | $192.50B | $54.04B |
Dividend Yield | 1.14% | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Analog Devices (ADI) trades at $381.17, down 1.07% today, with strong technical momentum showing bullish moving averages. The company demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $3.09 beating expectations of $2.89. Recent spin-off of ADI Global Distribution creates a more focused semiconductor pure-play. Valuation metrics remain elevated with P/E of 57.21 and P/S of 14.88, reflecting premium pricing for growth prospects.
Outlook remains positive with 79.6% analyst buy ratings and $472.29 consensus price target suggesting 24% upside. Key opportunities include industrial and data center growth with AI exposure, while risks include premium valuation sensitivity and semiconductor cycle volatility. Strong cash flow generation and dividend payments support shareholder returns amid market uncertainty.
Humana (HUM) trades at $384.97, up 3.26% in the last session, with a bullish technical signal and analyst consensus price target of $409.93. Recent earnings have consistently beaten expectations, and the company is focusing on Medicare Advantage margin expansion by 2027. Cash flow trends improved in 2025, though net income margins have declined from 3.02% in 2022 to 0.91% in 2025.
The outlook is cautiously optimistic, supported by revenue growth and strategic initiatives, but risks include margin pressure and regulatory uncertainty. Upside potential exists if management executes on cost reductions and Medicare Advantage plans, but investors should monitor profit sustainability amid competitive and economic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Analog Devices, Inc.
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
